CSIMarket
 

Abeona Therapeutics Inc   (ABEO)
Other Ticker:  
 

Abeona Therapeutics Inc 's Working Capital Per Sales

ABEO's Working Capital and Revenue growth



ABEO Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change 278.79 % 108.28 % 31.85 % 16.87 % -68.87 %
Y / Y Revenue Change 723.61 % 291.7 % 5.2 % -85.77 % -
Working Capital Per Revenue 7.74 6.71 14.79 13.78 5.38
Total Ranking # 2743 # 2666 # 3531 # 2262 # 2062
Seq. Working Capital Change 41.2 % -2.33 % -21.84 % 251.4 % -22.36 %
Seq. Revenue Change -84.86 % 976.1 % -14.75 % 493.06 % -92.8 %





Comment on ABEO's Working Capital Per Revenue in the third quarter 2023
Abeona Therapeutics Inc 's Working Capital Per Revenue sequentially grew to 7.74 during the Q3 2023, below the Abeona Therapeutics Inc average.

Within Healthcare sector 99 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Working Capital Per Revenue total ranking has deteriorated in the third quarter 2023, compared to previous quarter from 2666 to 2743.
Working Capital Per Revenue Ranking
Within: No.
Industry # 33
Sector # 100
S&P 500 # 2743


Working Capital Per Revenue Statistics
High Average Low
90.67
22.66
-12.11
(Dec 31 2017)   (Sep. 30, 2014)



Financial Statements
Abeona Therapeutics Inc 's Working Capital $ 49 Millions Visit ABEO's Balance sheet
Abeona Therapeutics Inc 's Revenues $ 1 Millions Visit ABEO's Income Statement
Where are ABEO's Sales coming from? Visit ABEO's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Ambrx Biopharma Inc   19.17 
Absci Corp  18.88 
Inovio Pharmaceuticals Inc   18.76 
Senti Biosciences Inc   18.41 
Verrica Pharmaceuticals Inc   17.75 
Intellia Therapeutics Inc   17.35 
Ideaya Biosciences Inc   16.89 
Bolt Biotherapeutics Inc   16.84 
Abcellera Biologics Inc   16.77 
Co diagnostics Inc   16.62 
Miromatrix Medical inc   16.11 
Syros Pharmaceuticals Inc   15.61 
Clearside Biomedical Inc   15.49 
Bicycle Therapeutics Plc  15.24 
Vir Biotechnology Inc   15.16 
Vaxart Inc   14.73 
Cue Biopharma Inc   13.45 
Roivant Sciences Ltd   13.40 
Editas Medicine Inc   12.70 
Tff Pharmaceuticals Inc   12.43 
Hyperfine Inc   12.14 
Lyell Immunopharma Inc   12.02 
4d Molecular Therapeutics Inc   11.54 
Asensus Surgical Inc   11.53 
Helius Medical Technologies inc   11.33 
C4 Therapeutics Inc   11.08 
Gritstone Bio Inc   10.90 
Longeveron Inc   10.80 
Ikena Oncology Inc   10.67 
Beam Therapeutics Inc   10.54 
Date modified: 2023-11-30T13:19:10+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com